SU

Healthcare · Healthcare Service Provider

Suraksha Diagnostic Ltd (SURAKSHA)

₹311.50

Mkt cap
₹1,841 Cr
P/E ratio
44.00
P/B
5.88
Div yield
0.14%
ROE
14.20%
ROCE
17.30%
EPS (TTM)
₹7.08
Book value
₹53
52W range
224–384
Sector
Healthcare

Price history

Previous close

Incorporated in 2005, Suraksha Diagnostic offers an integrated pathology, radiology testing, and medical consultancy services solution. [1]

NSE SURAKSHABSE 544293
Health check
Mixed
ValuationFair
ProfitabilityAverage
GrowthModerate
TechnicalsNeutral
52-week range
−18.88% from high
₹312
₹224+39.00% from low₹384
Current
₹311.50
Prev close
₹329.90
Day
−5.58%
Price performance
1D
−5.43%
1W
−8.69%
1M
+7.98%
3M
+2.24%
6M
−2.53%
1Y
+0.61%
YTD
+12.60%

Financials

Revenue, profit & margin
P/E ratio
44.0×
SURAKSHA is 16% above the sector median of 38.0×
SURAKSHA44.0×
Sector median38.0×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales60525561676065737978818899
YoY Sales growth+11%+15%+18%+20%+18%+31%+25%+21%+26%
Expenses39363640444146495555575764
Operating Profit21151921231819242423243035
OPM %35%30%35%34%35%31%29%33%31%30%30%35%35%
Other Income1101111111112
Interest2222222333445
Depreciation888999991011111113
Profit before tax1169111489121210101719
Tax %24%27%32%27%26%26%22%26%27%28%38%22%21%
Net Profit8568106799761315
EPS in Rs1.610.891.251.521.991.181.421.801.731.441.212.502.88
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +7.17% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast12 Aug '2610 Nov '26◦
Earnings day+12.61%+1.73%
+1 day+12.78%−2.68%
+5 days+12.87%−0.67%
+15 days+25.61%—
+30 days+26.98%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
49.10%Promoter
Promoters49.10%
FIIs13.98%0.51
DIIs21.56%1.66
Public15.37%1.17
Ownership trend

Peers

7 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Dr Lal Pathlabs₹1,980.2054.8933,2370.71%194+28.75%874+19.61%28.00%
Vijaya Diagnost.₹1,467.4074.2015,1140.14%59+37.41%255+26.71%20.53%
Metropolis Healt₹567.0050.9811,7670.35%75+43.04%497+15.76%17.81%
Thyrocare Tech.₹506.9546.118,0791.84%15−11.56%271+25.07%35.38%
Nephrocare Health Services₹667.7552.416,7150.00%34+454.07%303+23.47%15.34%
Suraksha Diagno.₹353.5044.021,8410.14%15+66.96%99+25.84%17.29%
Krsnaa Diagnost.₹518.7016.661,6830.39%25+8.95%240+31.17%12.71%
Median: 16 Co.₹369.1538.041,0130.07%15+10.52%83+24.27%21.66%

Filings